Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

National and International Clinical Guidelines for the Management of Obesity in Adults: A Systematic Review.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2026
Same author

Vascular endothelial growth factor inhibitors outcomes in good vision eyes with neovascular age-related macular degeneration: Fight Retinal Blindness! SPAIN Report 4.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2026
Same author

Ultra-widefield retinal imaging for early detection of asymptomatic cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation: a prospective pilot feasibility study.

Journal of ophthalmic inflammation and infection·2026
Same author

Interventions for submacular haemorrhage: A systematic review and network meta-analysis of controversies-On behalf of the Spanish Vitreo-Retinal Society (SERV).

Acta ophthalmologica·2025
Same author

Surgical Technique: Viscodissection for Managing Funnel Retinal Detachments.

Journal of clinical medicine·2025
Same author

Whole-mount Retinal Organoid Visualization with Cellular Resolution.

Journal of visualized experiments : JoVE·2025

Related Experiment Video

Updated: Dec 19, 2025

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

4.0K

Retinal Vasculitis Secondary to Durvalumab.

Antonio R Andrade1, Aina Moll-Udina2, Ruth Martin1

  • 1Ophthalmology Department, Vall d'Hebron, Facultat de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.

Case Reports in Ophthalmology
|June 9, 2020
PubMed
Summary

Checkpoint inhibitors like durvalumab rarely cause ocular side effects. This case shows retinal vasculitis and macular edema resolved with methylprednisolone, allowing continued cancer treatment.

Keywords:
Cancer therapyCheckpoint inhibitorsDurvalumabRetinaVasculitis

More Related Videos

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature
05:54

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature

Published on: January 24, 2025

575
In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
07:35

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

Published on: April 21, 2022

2.6K

Related Experiment Videos

Last Updated: Dec 19, 2025

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

4.0K
Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature
05:54

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature

Published on: January 24, 2025

575
In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
07:35

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

Published on: April 21, 2022

2.6K

Area of Science:

  • Ophthalmology
  • Oncology
  • Immunology

Background:

  • Checkpoint inhibitors, such as durvalumab, are increasingly used for cancer treatment.
  • Ocular side effects from these immunotherapies are uncommon but can be severe.

Observation:

  • A 64-year-old man receiving durvalumab for non-small-cell lung carcinoma developed retinal vasculitis.
  • The patient also presented with macular edema, a serious vision-threatening condition.

Findings:

  • Prompt treatment with three doses of methylprednisolone led to the resolution of retinal vasculitis.
  • Macular edema significantly improved during the follow-up period.

Implications:

  • This case highlights the importance of monitoring for rare ocular side effects of checkpoint inhibitors.
  • Early intervention with corticosteroids can effectively manage these adverse events, potentially avoiding treatment cessation.